BioLife Solutions, Inc. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
BioLife Solutions, Inc. (BLFS) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of -$91.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-08-06
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-06-30 was -$91.00K, a 339.47% decline year-over-year.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-03-31 was -$252.00K, a 2900.00% decline year-over-year.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-09-30 was $59.00K, a 9.23% decline year-over-year.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-06-30 was $38.00K.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2016 was $451.00, a 92.48% decline from fiscal 2015.
- BioLife Solutions, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2015 was $6.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$91.00K 10-Q · filed 2026-08-06 | -$343.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$252.00K 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | $59.00K 10-Q · filed 2025-11-06 | $97.00K derived: sum of 2 quarters · filed 2026-08-06 | $106.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $38.00K 10-Q · filed 2026-08-06 | $47.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $65.00K 10-Q · filed 2025-11-06 | $65.00K derived: sum of 2 quarters · filed 2025-11-06 | $46.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$18.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$18.00K 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-12 | $5.00K derived: sum of 2 quarters · filed 2024-11-12 | $44.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $40.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $39.00K 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | -$36.00K 10-Q · filed 2023-11-09 | -$76.00K derived: sum of 2 quarters · filed 2023-11-09 | -$75.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$40.00K 10-Q · filed 2023-08-09 | -$40.00K 10-Q · filed 2023-08-09 | ||
| 2017-12-31 | $0.00 10-K · filed 2018-03-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $451.00 10-K · filed 2018-03-09 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $451.00 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $451.00 10-Q · filed 2016-08-11 | ||
| 2016-03-31 | $451.00 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | $6.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |